MetaVia Ownership

MTVA Stock   0.67  0.04  5.63%   
The market capitalization of MetaVia is USD14.42 Million. MetaVia secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 63.46 % of MetaVia outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Some institutional investors establish a significant position in stocks such as MetaVia in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of MetaVia, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetaVia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.

MetaVia Stock Ownership Analysis

About 63.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.11. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MetaVia recorded a loss per share of 4.29. The entity last dividend was issued on the 31st of December 2019. The firm had 1:8 split on the 21st of December 2023. To find out more about MetaVia contact HyungHeon Kim at 857 702 9600 or learn more at https://www.metaviatx.com.
Besides selling stocks to institutional investors, MetaVia also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different MetaVia's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align MetaVia's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

MetaVia Quarterly Liabilities And Stockholders Equity

12.13 Million

About 63.0% of MetaVia are currently held by insiders. Unlike MetaVia's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against MetaVia's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of MetaVia's insider trades

MetaVia Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MetaVia insiders, such as employees or executives, is commonly permitted as long as it does not rely on MetaVia's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MetaVia insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MetaVia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MetaVia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Metavia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Metavia Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetaVia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetaVia. If investors know MetaVia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetaVia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.29)
Return On Assets
(0.74)
Return On Equity
(1.61)
The market value of MetaVia is measured differently than its book value, which is the value of MetaVia that is recorded on the company's balance sheet. Investors also form their own opinion of MetaVia's value that differs from its market value or its book value, called intrinsic value, which is MetaVia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetaVia's market value can be influenced by many factors that don't directly affect MetaVia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetaVia's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetaVia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetaVia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.